Enzymotec (ENZY) Misses Q4 EPS by 13c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/17/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- SanDisk upgraded at JPMorgan after investor day; shares climb
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Enzymotec (ENZY) PT Raised to $8 at Jefferies; Reiterates Hold
February 23, 2017 7:54 AM ESTJefferies raised its price target on Enzymotec (NASDAQ: ENZY) to $8.00 (from $7.00) while maintaining a Hold rating. Enzymotec's Q4 results were in line with the recent pronouncement. The company posted a Q4 loss of $0.10 on 20% lower revenue and a $2m inventory writeoff, which accounted for a... More
